Arrowhead Pharmaceuticals (UK) Buy Hold or Sell Recommendation
| 0HI3 Stock | 18.55 0.04 0.22% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Arrowhead Pharmaceuticals Corp is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Arrowhead Pharmaceuticals Corp given historical horizon and risk tolerance towards Arrowhead Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Arrowhead Pharmaceuticals Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Arrowhead Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide. Note, we conduct extensive research on individual companies such as Arrowhead and provide practical buy, sell, or hold advice based on investors' constraints. Arrowhead Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Arrowhead |
Execute Arrowhead Pharmaceuticals Buy or Sell Advice
The Arrowhead recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Arrowhead Pharmaceuticals Corp. Macroaxis does not own or have any residual interests in Arrowhead Pharmaceuticals Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Arrowhead Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Arrowhead Pharmaceuticals Trading Alerts and Improvement Suggestions
| Arrowhead Pharmaceuticals generated a negative expected return over the last 90 days | |
| Arrowhead Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 240.74 M. Net Loss for the year was (209.28 M) with profit before overhead, payroll, taxes, and interest of 240.74 M. | |
| Arrowhead Pharmaceuticals generates negative cash flow from operations | |
| Over 80.0% of the company shares are owned by institutions such as pension funds |
Arrowhead Pharmaceuticals Returns Distribution Density
The distribution of Arrowhead Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Arrowhead Pharmaceuticals' future price movements. The chart of the probability distribution of Arrowhead Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Arrowhead Pharmaceuticals Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Arrowhead Pharmaceuticals returns is essential to provide solid investment advice for Arrowhead Pharmaceuticals.
| Mean Return | -0.29 | Value At Risk | -5.13 | Potential Upside | 4.86 | Standard Deviation | 3.12 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Arrowhead Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Arrowhead Pharmaceuticals Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.3M) | 1.6M | 9.2M | (3.4M) | (3.9M) | (4.1M) | |
| Change In Cash | (78.2M) | 40.9M | (76.4M) | 2.9M | 3.3M | 4.5M | |
| Free Cash Flow | (107.3M) | 147.7M | (188.9M) | (330.6M) | (297.6M) | (282.7M) | |
| Depreciation | 5.9M | 8.3M | 10.4M | 12.5M | 14.4M | 15.1M | |
| Other Non Cash Items | 525.3K | 266K | 7.3M | 16.3M | 18.8M | 19.7M | |
| Capital Expenditures | 12.0M | 23.6M | 52.8M | 176.7M | 203.2M | 213.4M | |
| Net Income | (84.6M) | (140.8M) | (176.5M) | (209.3M) | (188.3M) | (178.9M) | |
| End Period Cash Flow | 143.6M | 184.4M | 108.0M | 110.9M | 127.5M | 133.9M | |
| Investments | (228.8M) | (118.1M) | 47.4M | 80.6M | 92.7M | 97.3M | |
| Change To Netincome | 43.9M | 75.2M | 127.8M | 90.4M | 104.0M | 57.5M |
Arrowhead Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arrowhead Pharmaceuticals or Commercial Services & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arrowhead Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arrowhead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.3 | |
β | Beta against Dow Jones | 0.02 | |
σ | Overall volatility | 2.99 | |
Ir | Information ratio | -0.12 |
Arrowhead Pharmaceuticals Volatility Alert
Arrowhead Pharmaceuticals Corp exhibits very low volatility with skewness of -0.16 and kurtosis of 1.33. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arrowhead Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arrowhead Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Arrowhead Pharmaceuticals Fundamentals Vs Peers
Comparing Arrowhead Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arrowhead Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Arrowhead Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arrowhead Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Arrowhead Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Arrowhead Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Arrowhead Pharmaceuticals to competition |
| Fundamentals | Arrowhead Pharmaceuticals | Peer Average |
| Return On Equity | -1.52 | -0.31 |
| Return On Asset | -0.41 | -0.14 |
| Operating Margin | (27.85) % | (5.51) % |
| Current Valuation | 2.34 B | 16.62 B |
| Shares Outstanding | 88.02 M | 571.82 M |
| Shares Owned By Insiders | 4.46 % | 10.09 % |
| Shares Owned By Institutions | 79.60 % | 39.21 % |
| Price To Sales | 92.86 X | 11.42 X |
| Revenue | 240.74 M | 9.43 B |
| Gross Profit | 240.74 M | 27.38 B |
| EBITDA | (175.67 M) | 3.9 B |
| Net Income | (209.28 M) | 570.98 M |
| Total Debt | 115.17 M | 5.32 B |
| Book Value Per Share | 2.66 X | 1.93 K |
| Cash Flow From Operations | (153.89 M) | 971.22 M |
| Earnings Per Share | (1.07) X | 3.12 X |
| Number Of Employees | 525 | 18.84 K |
| Beta | 0.93 | -0.15 |
| Market Capitalization | 182.46 B | 19.03 B |
| Total Asset | 765.55 M | 29.47 B |
| Retained Earnings | (1.03 B) | 9.33 B |
| Net Asset | 765.55 M |
Arrowhead Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Arrowhead . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Arrowhead Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Arrowhead Pharmaceuticals Corp? Buying financial instruments such as Arrowhead Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Arrowhead Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronics Thematic Idea Now
Electronics
Companies manufacturing electronic appliances and goods. The Electronics theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.